HCA Health Inc vs IDEXX Laboratories, Inc. — how do they compare? HCA Health Inc trades at $373.29 (market cap $82.17B), while IDEXX Laboratories, Inc. trades at $563.81 (market cap $44.48B). The key difference: HCA Health Inc is the larger of the two by market cap, and HCA Health Inc pays a 0.84% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| HCA | IDXX | |
|---|---|---|
Market Cap | $82.17B | $44.48B |
Sector | Health | Health |
52-Week High | $545.13 | $766.68 |
52-Week Low | $334.32 | $520.87 |
Enterprise Value | $131.08B | $45.38B |
Dividend Yield | 0.84% | — |
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $373.09, up 0.51% with bearish technical signals despite strong fundamentals. The company reported Q2 2026 preliminary revenue above expectations but cut full-year profit guidance, causing recent stock pressure. Analyst consensus remains bullish with a $469.40 price target, though multiple law firms are investigating potential securities law violations following the guidance revision.
Investment outlook balances strong operational performance against near-term headwinds. The stock offers value with a 12.76 P/E ratio and consistent earnings beats, but faces risks from rising expenses, payer mix challenges, and ongoing legal investigations. Institutional sentiment remains positive despite technical weakness and recent guidance concerns.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →